Evidence map›Paper›PMID 24288131›Full record

ArticleThe Journal of biological chemistry2014

Peroxisome proliferator-activated receptor γ regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes.

Frédérik Oger, Julie Dubois-Chevalier, Céline Gheeraert, Stéphane Avner, Emmanuelle Durand, Philippe Froguel, Gilles Salbert, Bart Staels, Philippe Lefebvre, Jérôme Eeckhoute

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Inhibition of triglyceride metabolism-associated enhancers alters lipid deposition during adipocyte differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Anti-Obesity Effects ofNutrients · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The increasingly complex regulation of adipocyte differentiation.Experimental biology and medicine (Maywood, N.J.) · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Frédérik OgerFrom INSERM UMR U1011, F-59000 Lille, France.
Julie Dubois-Chevalier
Céline Gheeraert
Stéphane Avner
Emmanuelle Durand
Philippe Froguel
Gilles Salbert
Bart Staels
Philippe Lefebvre
Jérôme Eeckhoute
European Genomic Institute for Diabetes · FRUniversité de Lille · FRUniversité de Rennes · FRInstitut Pasteur de Lille · FR

Funding

Medical Research Council G1002084
6 · The paper itself

Abstract

The nuclear receptor peroxisome proliferator-activated receptor (PPAR) is a transcription factor whose expression is induced during adipogenesis and that is required for the acquisition and control of mature adipocyte functions. Indeed, PPAR induces the expression of genes involved in lipid synthesis and storage through enhancers activated during adipocyte differentiation. Here, we show that PPAR also binds to enhancers already active in preadipocytes as evidenced by an active chromatin state including lower DNA methylation levels despite higher CpG content. These constitutive enhancers are linked to genes involved in the insulin/insulin-like growth factor signaling pathway that are transcriptionally induced during adipogenesis but to a lower extent than lipid metabolism genes, because of stronger basal expression levels in preadipocytes. This is consistent with the sequential involvement of hormonal sensitivity and lipid handling during adipocyte maturation and correlates with the chromatin structure dynamics at constitutive and activated enhancers. Interestingly, constitutive enhancers are evolutionary conserved and can be activated in other tissues, in contrast to enhancers controlling lipid handling genes whose activation is more restricted to adipocytes. Thus, PPAR utilizes both broadly active and cell type-specific enhancers to modulate the dynamic range of activation of genes involved in the adipogenic process.

Indexed as

Gene Expression Regulation, Developmental3T3-L1 CellsAdipocytesAdipogenesisAnimalsCell LineChromatin ImmunoprecipitationEnhancer Elements, GeneticInsulinLipid MetabolismMiceMuscle Fibers, SkeletalPPAR gammaProtein BindingReverse Transcriptase Polymerase Chain ReactionSignal TransductionInsulinPPAR gammaSomatomedinsAdipogenesisChromatin ModificationDNA MethylationEpigenomicsInsulin/Insulin-like Growth Factor SignalingPeroxisome Proliferator-activated Receptor (PPAR)Transcription EnhancersTranscription Regulation

Identifiers

PMID24288131
PMCPMC3887199
OpenAlexW1531179211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.